The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide also reduces body weight. It is not fully understood how liraglutide induces weight loss or to what degree liraglutide acts directly in the brain. Here,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Secher, Anna, Jelsing, Jacob, Baquero, Arian F., Hecksher-Sørensen, Jacob, Cowley, Michael A., Dalbøge, Louise S., Hansen, Gitte, Grove, Kevin L., Pyke, Charles, Raun, Kirsten, Schäffer, Lauge, Tang-Christensen, Mads, Verma, Saurabh, Witgen, Brent M., Vrang, Niels, Bjerre Knudsen, Lotte
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Clinical Investigation 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215190/
https://ncbi.nlm.nih.gov/pubmed/25202980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75276
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi